Clinical Pharmacokinetics of Amifostine and WR1065 in Pediatric Patients With Medulloblastoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-1997
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Pharmacokinetics of Pirarubicin in Pediatric Patients.

Journal of Pharmacobio-Dynamics
1991English

Pharmacokinetics of Potassium Clavulanate in Combination With Amoxicillin in Pediatric Patients.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1982English

Association of Aggresomes With Survival Outcomes in Pediatric Medulloblastoma

Scientific Reports
Multidisciplinary
2019English

Epigenetic Drivers in Pediatric Medulloblastoma

Cerebellum
MedicineNeurology
2017English

Pharmacokinetics of Ciprofloxacin in Pediatric Cystic Fibrosis Patients.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1996English

Population Pharmacokinetics and Dosing Optimization of Linezolid in Pediatric Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Clinical Pharmacokinetics of Aztreonam in Cancer Patients.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1984English

Quality of Life in Patients With Proton-Treated Pediatric Medulloblastoma: Results of a Prospective Assessment With 5-Year Follow-Up

Cancer
Cancer ResearchOncology
2018English

Ceftolozane/Tazobactam Population Pharmacokinetics and Dose Selection for Further Clinical Evaluation in Pediatric Patients With Complicated Urinary Tract or Complicated Intraabdominal Infections

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy